Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control [NA]

View source ↗

Summary

This document provides an update on the INTEGRA trial, a primary care intervention study for patients with Type 2 diabetes and poor glycemic control.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED